Access to anti-retroviral drugs, female in Madagascar
Madagascar: Access to anti-retroviral drugs, female was 39.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Madagascar, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Madagascar stood at 39.0%. That is the highest value across all 25 years on record.
The figure is up 34.5% on the previous year and up 1,200.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Madagascar peaked at 39.0% in 2024 and was at its lowest, 0.0%, in 2000.
Madagascar ranks 128th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Madagascar, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 1.0% | — |
| 2007 | 1.0% | +0.0% |
| 2008 | 1.0% | +0.0% |
| 2009 | 1.0% | +0.0% |
| 2010 | 1.0% | +0.0% |
| 2011 | 2.0% | +100.0% |
| 2012 | 1.0% | -50.0% |
| 2013 | 2.0% | +100.0% |
| 2014 | 3.0% | +50.0% |
| 2015 | 4.0% | +33.3% |
| 2016 | 5.0% | +25.0% |
| 2017 | 6.0% | +20.0% |
| 2018 | 9.0% | +50.0% |
| 2019 | 12.0% | +33.3% |
| 2020 | 13.0% | +8.3% |
| 2021 | 19.0% | +46.2% |
| 2022 | 23.0% | +21.1% |
| 2023 | 29.0% | +26.1% |
| 2024 | 39.0% | +34.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.4% | 0.0% | 1.0% | 10 |
| 2010s | 4.5% | 1.0% | 12.0% | 10 |
| 2020s | 24.6% | 13.0% | 39.0% | 5 |
Countries ranked near Madagascar
More gender data for Madagascar
- Child population (UN estimates and projections) 13,788 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.52 % change on previous year (2030)
- Population 22,905 (2030)
- Working-age population (UN estimates and projections) 22,905 (2030)
- Population (UN estimates and projections), annual growth rate 2.66 % change on previous year (2030)
- Age population, age 00, female, interpolated 483,299 (2025)
- Age population, age 00, male, interpolated 498,396 (2025)
- Age population, age 01, female, interpolated 473,008 (2025)
- Age population, age 01, male, interpolated 486,670 (2025)
- Age population, age 02, female, interpolated 464,238 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Madagascar?
- Access to anti-retroviral drugs, female in Madagascar was 39.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Madagascar?
- The highest recorded value was 39.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Madagascar?
- The lowest recorded value was 0.0% in 2000.
- How does Madagascar rank for access to anti-retroviral drugs, female?
- Madagascar ranks 128th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Madagascar?
- Over the last ten years it is up 1,200.0%. The long-run trend across the full record is volatile.
- Where does this Madagascar data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.